American Society of Nephrology Journals Maintain High Ranking and Impact among Kidney Journals

Newswise — Washington, DC (June 21, 2019)—JASN maintains the highest impact ranking among kidney journals, according to a newly announced rating. Journal Citation Reports® (JCR) released its Impact Factor scores for 2018, and JASN earned a score of 8.5. This Impact Factor reflects the journal’s influence, based on the average annual number of citations in 2018 to articles published in a journal during 2016 and 2017. JASN was referenced more than any publication in the field.

Physicians and scientists read the journal, established in 1990, to discover advances in renal disease, including dialysis, transplantation, immunology, hemodynamics, bone disease, clinical nephrology, epidemiology, and patient outcomes.

JCR also reported that the society’s CJASN Impact Factor increased 7% from 5.8 to 6.2 in one year, increasing by 23% in two years. CJASN publishes relevant research and reviews about in-and outpatient kidney disease care. Physicians read CJASN to learn about key clinical outcomes in critical care, dialysis, kidney medicine, and metabolism.

“It’s exciting to see that our journal was ranked number one for influence in its field. Everyone works hard to produce an excellent journal that can ultimately have a huge impact on patients’ lives,” said Josephine P. Briggs, MD, JASN Editor-in-Chief.

CJASN Editor-in-Chief Rajnish Mehrotra, MD, concurs. “CJASN’s impact factor growth reflects our editorial team’s diligence in peer-review and ability to identify manuscripts that move the nephrology field forward and have the potential to improve the health and welfare of patients with kidney diseases. Thank you to our authors for choosing CJASN to publish their research,” he said.

JCR evaluates the world's leading journals, with quantifiable, statistical information based on citation data. Then compiling articles' cited references, JCR measures research influence and impact at the journal and category levels and shows the relationship between citing and cited journals.

# # #

Since 1966, ASN has been leading the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients. ASN has more than 20,000 members representing 131 countries. For more information, please visit or contact the society at 202-640-4660.